GI
RMD icon

GAMMA Investing’s ResMed RMD Stock Holding History

GAMMA Investing’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.04M Buy
4,691
+1,045
+29% +$228K 0.04% 416
2026
Q2 		$711K Sell
3,646
-744
-17% -$154K 0.03% 508
2026
Q1 		$985K Buy
4,390
+99
+2% +$24.7K 0.05% 348
2025
Q4 		$1.03M Sell
4,291
-107
-2% -$27.4K 0.05% 302
2025
Q3 		$1.2M Buy
4,398
+555
+14% +$152K 0.07% 245
2025
Q2 		$991K Buy
3,843
+566
+17% +$135K 0.06% 273
2025
Q1 		$734K Buy
3,277
+231
+8% +$53.9K 0.06% 306
2024
Q4 		$697K Buy
3,046
+545
+22% +$131K 0.06% 283
2024
Q3 		$611K Buy
2,501
+1,177
+89% +$263K 0.06% 284
2024
Q2 		$253K Buy
1,324
+476
+56% +$96.6K 0.03% 436
2024
Q1 		$168K Buy
848
+199
+31% +$36.5K 0.03% 450
2023
Q4 		$123K Buy
+649
New +$99.7K 0.03% 459

Other funds holding RMD

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
BRCM
Bright Rock Capital Management Hanover, Massachusetts $529M AUM 8.66% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
HWA
Heartwood Wealth Advisors Richmond, Virginia $1.27B AUM 11.08% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
ANBT
American National Bank & Trust Wichita Falls, Texas $1.09B AUM 26.59% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

GAMMA Investing's RMD Position: Q3 2026 in Review

GAMMA Investing increased its ResMed (RMD) stake by 29% in Q3 2026, buying an estimated $228K and bringing the position to 4,691 shares worth $1.04M. The position accounts for 0.04% of the portfolio, ranked #416.

GAMMA Investing first reported a position in RMD in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.2M in Q3 2025. 22 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • GAMMA Investing held 4,691 shares of ResMed worth $1.04M as of Q3 2026.
  • GAMMA Investing bought 1,045 ResMed shares in Q3 2026, an estimated $228K.
  • ResMed made up 0.04% of GAMMA Investing's portfolio in Q3 2026, its #416 holding.
  • GAMMA Investing first reported a position in ResMed in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's ResMed position peaked at $1.2M in Q3 2025.
  • 22 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.